Categories: Technology

11x Raises a $50 Million Series B Led by Andreessen Horowitz to Accelerate the Era of Digital Workers

SAN FRANCISCO, Nov. 11, 2024 (GLOBE NEWSWIRE) — 11x, the leader in AI-powered digital workers for revenue teams, today announced the closing of a $50 million Series B funding round led by Andreessen Horowitz. The investment accelerates 11x’s digital workers further into the era of AI agents.

“11x’s approach to sales automation with Alice and Jordan isn’t just about optimizing workflows. It’s about creating a new model for how work gets done,” said Joe Schmidt, Partner at Andreessen Horowitz. “We’re proud to support 11x as they reshape what’s possible in sales.”

The End of Software

Sales teams are buried under an avalanche of tools, with over half now aiming to reduce their tech stacks according to Salesforce’s latest State of Sales report. Only 30% of sales reps’ time is spent selling, with 70% lost to non-selling tasks like data entry and system management. 11x addresses this imbalance with digital workers that autonomously handle the workflows of traditional revenue teams.

Digital Workers, Not Software

The company’s first two digital workers have demonstrated remarkable results:

  • Alice, the world’s first AI SDR, manages campaigns, sources leads, and personalizes outreach, driving response rates 3x higher than traditional SDRs.
  • Jordan, a 24/7 multilingual phone rep, handles calls in over 30 languages, delivering up to 10x faster lead response times.

Now 11x has doubled down on delivering truly autonomous outcomes for customers by developing an entirely new version of Alice using the latest agentic AI research: Alice 2.0.

Alice 2.0 is fully autonomous, leverages first-party data, and learns from every interaction to improve over time.

Strategic Growth and Future Plans

Following a significant team expansion in the US after their Series A this September, 11x has acquired Opkit, an AI startup focused on developing healthcare solutions. Opkit co-founders Sherwood Callaway and Justin Ko will lead development on Alice 2.0 with product leader Keith Fearon, joining forces with 11x CTO Prabhav Jain.

In the next year, 11x plans to launch multiple new AI agents while driving aggressive revenue growth and key hiring initiatives in San Francisco.

“We’re seeking bold innovators ready to shape the future of AI,” explained CEO and Founder Hasan Sukkar. “Each new digital worker will replace the work of 11 full-time employees, managing an even broader range of GTM tasks from lead management to pipeline analytics.”

About 11x

11x is redefining work by replacing software with autonomous digital workers that automate Go-to-Market (GTM) workflows, helping organizations increase efficiency and cut costs. 11x specializes in automating roles across GTM teams, including Sales, Marketing, and Revenue Operations.

The company is backed by Andreessen Horowitz, Benchmark, Quiet Capital, SV Angel, Abstract Ventures, Lux Capital, Operator Partners, Visionaries, Activant, 20VC, 20Growth, 20Sales, and industry pioneers such as Amjad Masad (CEO of Replit), Aaron Levie (CEO of Box), and Suhail Doshi (Founder of Playground).

Media Contacts:
Keith Fearon – Head of Growth & Alice Product @ 11x
Email: keith@11x.ai

Photos accompanying this announcement are available at

https://www.globenewswire.com/NewsRoom/AttachmentNg/524ca0ec-5198-4406-a2f9-9cee8f3a1403

https://www.globenewswire.com/NewsRoom/AttachmentNg/be6218c4-8782-4215-b4a9-8865a5e7e543

GlobeNews Wire

Recent Posts

KFSHRC Madinahs Virtual Clinics Wins Award at PX Congress

RIYADH, Saudi Arabia, Nov. 20, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital and Research…

5 hours ago

IBA Business Update Third Quarter 2024

Louvain-la-Neuve, Belgium, 21 November 2024 - IBA (Ion Beam Applications S.A), the world leader in…

5 hours ago

Novartis upgrades mid-term guidance and highlights deep pipeline in core therapeutic areas to drive long-term growth

Ad hoc announcement pursuant to Art. 53 LR Mid-term sales guidance upgraded to +6% CAGR…

5 hours ago

Kura Oncology and Kyowa Kirin Announce Global Strategic Collaboration to Develop and Commercialize Ziftomenib in Acute Leukemias

– Kura to receive a $330 million upfront payment and up to $1.2 billion in…

5 hours ago

Onco360 Has Been Selected as a National Specialty Pharmacy Partner for Revuforj (revumenib)

LOUISVILLE, Ky., Nov. 20, 2024 (GLOBE NEWSWIRE) -- Onco360®, the nation’s leading independent Specialty Pharmacy,…

5 hours ago

Las Vegas Unveils Exclusive Entertainment, Packages and More for Race Week 2024

Destination Revving up This Year’s Excitement with Top-Tier Entertainment, Luxurious Trackside Experiences and Celebrations like…

8 hours ago